FDA inspection
GlaxoSmithKline Vaccines Srl: FDA inspection ending Jan 26, 2024
FDA inspection 1227972 · Voluntary Action Indicated (VAI) · Sovicille
Key facts
| Inspection ID | 1227972 |
|---|---|
| Firm | GlaxoSmithKline Vaccines Srl |
| FEI number | 3006738517 |
| Address | Localita Bellaria |
| City | Sovicille |
| Country | Italy |
| Fiscal year | 2024 |
| Inspection end date | Jan 26, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Vaccines and Allergenic Products |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data